missing translation for 'onlineSavingsMsg'
Få mere at vide

Tocris Bioscience™ Varenicline tartrate
GREENER_CHOICE

Artikelnummer. 18712524
Klik for at se tilgængelige muligheder
Mængde:
10 mg
50 mg
Denne vare kan ikke returneres. Se returpolicy
Regulatorisk: Dette produkt falder ind under Lov om kemiske stoffer og produkter - lovbekendtgørelse nr. 1755 af 22. december 2006. Hvis det er relevant, skal kunden fremskaffe en licens før levering.

Artikelnummer. 18712524

Brand: Tocris Bioscience™ 3754/10

Venligst for at købe denne vare. Brug for en webkonto? Register dig hos os i dag!

Denne vare kan ikke returneres. Se returpolicy
Regulatorisk: Dette produkt falder ind under Lov om kemiske stoffer og produkter - lovbekendtgørelse nr. 1755 af 22. december 2006. Hvis det er relevant, skal kunden fremskaffe en licens før levering.

Selective α4β2 partial agonist; orally active

Orally active, subtype-selective partial agonist at α4β2 nicotinic receptors (Ki values are 0.06, 240, 322 and 3540 nM for α4β2, α3β4, α7, α1βγδ receptors respectively). Reduces nicotine-evoked dopamine release in vitro and decreases nicotine self-administration in vivo. Also potently activates PSAM4-5-HT3 and PSAM4-GlyR chimeric ion channels (EC50 values are 4 and 1.6 nM, respectively)
TRUSTED_SUSTAINABILITY

Kemiske identifikatorer

CAS 375815-87-5
Molekylær formel C17H19N3O6

Specifications

Kemisk navn eller materiale Varenicline tartrate
Mængde 10 mg
Formel vægt 361.37
Renhed >99%
Molekylvægt (g/mol) 361.354
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.